Labcorp price target raised to $282 from $271 at BofA

BofA raised the firm’s price target on Labcorp (LH) to $282 from $271 and keeps a Buy rating on the shares after the company reported “solid” Q4 results and initiated FY25 sales guidance that at the midpoint was ahead of BofA and Street estimates. The core lab business is executing well and valuation is “not challenging,” the analyst tells investors.